Concordance, Correlation, and Clinical Impact of Standardized PD-L1 and TIL Scoring in SCCHN

SIMPLE SUMMARY: In patients with relapsed or metastasized squamous cell cancer of the head and neck (R/M SCCHN), the PD-L1 Combined Positive Score (CPS) is currently the only predictive biomarker for treatment with anti-PD-1 agents. However, ambiguous results have been determined regarding the overa...

Descripción completa

Detalles Bibliográficos
Autores principales: De Keukeleire, Stijn Jeroen, Vermassen, Tijl, Deron, Philippe, Huvenne, Wouter, Duprez, Fréderic, Creytens, David, Van Dorpe, Jo, Ferdinande, Liesbeth, Rottey, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139955/
https://www.ncbi.nlm.nih.gov/pubmed/35626035
http://dx.doi.org/10.3390/cancers14102431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139955/
https://www.ncbi.nlm.nih.gov/pubmed/35626035
http://dx.doi.org/10.3390/cancers14102431

Ejemplares similares